美國Marina Biotech
基于RNA干擾(RNAi)治療產品的開發和商品化為重點。我們正在建設的多個尖端藥物發現和開發平臺的基礎上,沒有一個單一的RNAi技術或交付方法可以廣泛應用到所有人類疾病的治療的前提下。
Marina Biotech is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). We are building multiple cutting-edge drug discovery and development platforms based on the premise that no single RNAi technology or delivery approach can be broadly applied to the treatment of all human diseases.